Saluda Medical Stock
Saluda Medical developers closed-loop neuron modulation devices intended to treat chronic neuropathic pain. The company's devices are used for the patient's neural fingerprint to monitor and adapt the dose of electrical stimulation automatically and tailor the therapy to meet each patient's needs in real-time, enabling patients with chronic back pain to get improved treatment.
Management Team
| Jim Schuermann President and Chief Executive Officer |
| James Erickson Chief Financial Officer |
| Robert Gaffney Chief Operating Officer |
| Dan Brounstein Chief Strategy Officer |
| Peter Single Chief Technology Officer |
| Yolanda Blasing Chief Accounting Officer |
| Kristin Caplice Chief Legal Officer |
| Tim Benner Chief Commercial Officer |
| Steven McQuillan Chief Clinical and Regulatory Officer |
